您的位置: 首页 > 农业专利 > 详情页

HETEROCYCLYMETHYL-THIENOURACILE AS ANTAGONISTS OF THE ADENOSINE-A2B-RECEPTOR
专利权人:
BAYER PHARMA AKTIENGESELLSCHAFT
发明人:
HARTER, Michael,KOSEMUND, Dirk,DELBECK, Martina,KALTHOF, Bernd,WASNAIRE, Pierre,SUSSMEIER, Frank,LUSTIG, Klemens
申请号:
PH12017501758
公开号:
PH12017501758A1
申请日:
2017.09.25
申请国别(地区):
PH
年份:
2018
代理人:
摘要:
The invention relates to novel, in position 6, a particular type of (aza-heterocyclyl)methyl-substituents carrying thieno[2,3-d]pyrimidine-2,4-dione ("thienouracil")-derivative, to methods for the production thereof, to the use thereof alone or in combinations for treating and/or preventing diseases, and to the use thereof for producing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of pulmonary and cardiovascular disorders and cancers.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充